Evidence map›Paper›PMID 41006331›Full record

ArticleScientific reports2025

Vision transformer-powered conversational agent for real-time Indian Sign Language e-governance accessibility.

Prema Nedungadi, Gautham Dileep, M Geetha, Raghu Raman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prema NedungadiAmrita School of Computing, Amrita Vishwa Vidyapeetham, Amritapuri, India. prema@amrita.edu.
Gautham DileepAmrita CREATE, Amrita Vishwa Vidyapeetham, Amritapuri, India. gauthamkd@am.amrita.edu.
M GeethaAmrita School of Computing, Amrita Vishwa Vidyapeetham, Amritapuri, India. geetham@am.amrita.edu.
Raghu RamanAmrita School of Business, Amrita Vishwa Vidyapeetham, Amritapuri, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a vision transformer-based, context-aware, real-time Indian Sign Language (ISL) conversational agent designed to enhance digital accessibility for India's Deaf and Hard-of-Hearing community within e-governance services. The system supports continuous sign language recognition, from isolated words to full ISL sentences, and delivers information and services directly in sign language. A domain-specific ISL video dataset, incorporating diverse signing styles and environments, addresses ISL's low-resource challenges, enabling robust, scalable real-world deployment. The hybrid architecture, combining convolutional neural networks with vision transformer models, effectively handles ISL's spatial-temporal complexities, maintaining reliability even with complex queries. A dynamic context-response mapping engine uses contextual data to increase accuracy, particularly for ambiguous inputs. The modular design ensures efficient scalability, facilitating seamless integration of new services. System evaluations, including stress testing and usability studies, confirmed its effectiveness in enabling real-time, inclusive digital interactions. Under optimized conditions, the system achieved 97.5% accuracy, a mean response time of 6.53 s, and an average system usability score of 71.83, significantly advancing digital inclusion in India.

Indexed as

Sign LanguageHumansIndiaNeural Networks, ComputerPersons with Hearing DisabilitiesArtificial intelligenceAssistive technologyAugmentative and alternative communicationChatbotDigital IndiaGesture recognitionVideo recognition

Identifiers

PMID41006331
PMCPMC12475093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.